| |
Negative VTE (n = 22)
|
Positive for VTE (n = 9)
|
p-Value
|
|---|
|
Demographics
|
|
Age (years), mean (SD)
|
59.0 (17.2)
|
59.5 (14.5)
|
–
|
|
Female, n (%)
|
7 (31.8%)
|
3 (33.3%)
|
–
|
|
BMI (kg/m2), mean (SD)
|
31.3 (9.1)
|
32.7 (9.1)
|
–
|
|
Prior anticoagulation therapy
|
0 (0.0%)
|
0 (0.0%)
|
–
|
|
Comorbidities, n (%)
|
|
Hypertension
|
11 (50.0%)
|
2 (22.2%)
|
0.15
|
|
Cardiovascular disease
|
0 (0.00%)
|
4 (44.4%)
|
0.0008
|
|
COPD
|
2 (9.09%)
|
3 (33.3%)
|
0.10
|
|
OSA
|
1 (4.55%)
|
1 (11.1%)
|
0.50
|
|
Hepatitis
|
0 (0.00%)
|
1 (11.1%)
|
0.11
|
|
Peripheral vascular disease
|
1 (4.55%)
|
1 (11.1%)
|
0.50
|
|
Malignancy
|
1 (4.55%)
|
1 (11.1%)
|
0.50
|
|
Diabetes
|
9 (40.9%)
|
1 (11.1%)
|
0.10
|
|
Renal failure
|
1 (4.55%)
|
4 (44.4%)
|
0.006
|
|
Paraplegia
|
0 (0.00%)
|
1 (11.1%)
|
0.11
|
|
Singulitis
|
0 (0.00%)
|
1 (11.1%)
|
0.11
|
|
Disposition, n (%)
|
|
ICU
|
0 (0.00%)
|
5 (55.5%)
|
0.0001
|
|
Intubation
|
0 (0.00%)
|
5 (55.5%)
|
0.0001
|
|
Death no.
|
0 (0.00%)
|
1 (11.1%)
|
0.11
|
